Researchers Publish First Human Data on Psychedelics Against Inflammation in Neurodegenerative Disease
Updated
Updated · NPR · Oct 21
Researchers Publish First Human Data on Psychedelics Against Inflammation in Neurodegenerative Disease
3 articles · Updated · NPR · Oct 21
Summary
First human data suggests psychedelics could reduce inflammation in patients with neurodegenerative diseases, extending earlier findings beyond lab studies.
Psilocybin and related compounds had already shown anti-inflammatory effects in laboratory research, raising hopes they may help protect against illnesses such as Parkinson's disease.
The new report stops short of proving treatment benefit, but it signals a possible new path for tackling inflammation linked to neurodegeneration.